Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

EPA Seeks Submissions On New Rodent Poison

The Environmental Protection Authority (EPA) is calling for submissions on difenacoum, a poison used to control rats and mice.

PelGar International Limited has applied for approval to import or manufacture for release two types of ready-to-use rodent baits containing difenacoum, an anticoagulant.

Difenacoum is a vertebrate toxic agent (VTA) that is new to Aotearoa New Zealand, but is approved in Australia, Europe, and the USA. The applicant seeks approval for use by both professional and non-professional users, however use would be restricted to specified bait stations.

Among the benefits listed by the applicant are low toxicity to humans and non-target animals, and reduced risk of secondary poisoning compared with substances containing flocoumafen and brodifacoum - active ingredients already approved for use in New Zealand.

The EPA has reviewed the material submitted by PelGar International and carried out a human health and environmental risk assessment. You can find more information about the EPA’s risk assessment process in the EPA’s draft science memorandum.

This public consultation enables the wider public and those in relevant industries to provide additional information on the risks and benefits of using difenacoum. Submitters can provide information, make comments, and raise issues to contribute to the EPA decision-making process.

Submissions close at 5.00 pm on 16 September 2022.

Find out more about difenacoum and make a submission

Watch this short video to learn how the EPA makes decisions about hazardous substances

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.